Keyword: London

The actions are part of the biotech’s ongoing efforts to seek a way out of its R&D-triggered troubles. 

The fund will pump the money into biotechs and other longevity startups based around the world in seed to series B rounds.

The flag lowering took place as the European Medicines Agency “symbolically said goodbye” to the city it has called home since its creation in 1995.

The relocation will see Novartis set up in the White City Place development next to Imperial College London’s new campus.

The initiative is seeking to build on the progress of British cell and gene therapy university spinouts such as Autolus and Orchard Therapeutics.

Perhaps nothing is more divisive in Britain today than Brexit. But what does it mean for R&D?

New research out by the BMJ shows that half of tracked clinical trials across Europe “have not reported trials.”

FundamentalVR launched a virtual surgery platform that uses physical feedback to create a tactile, flight simulator-like experience for surgeons.

Sensyne Health plans to go public with a £60 million listing ($77 million) on the London Stock Exchange on Aug. 17.

An AI startup raised $1 million to develop “machine reading” programs to digest and distill published biomedical literature and research.